Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

    Funding for early phase clinical trials of natural products, including botanicals and dietary supplements, to assess impact on target engagement and patient outcomes.

    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant is no longer accepting proposals

    National Institutes of Health has archived this opportunity.

    Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

    NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.

    HHS-NIH11Forecasted Jul 31, 2027Forecasted

    Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

    Supporting feasibility trials of mind and body interventions for high-priority health conditions to inform future clinical trials for enhanced public health impact.

    HHS-NIH11Due Nov 17, 2026· 1d$450,000

    Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

    This grant funds innovative natural history studies to improve understanding and support medical product development for rare diseases with unmet needs.

    HHS-FDA$400,000Forecasted

    Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

    Funding for clinical trials testing complementary health interventions remotely, emphasizing safety and feasibility with mHealth tools, requiring a diverse perspective plan.

    HHS-NIH11Due Nov 17, 2026· 1d

    Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

    This grant funds innovative natural history studies to advance medical product development and address unmet needs in rare diseases by generating high-quality, interpretable data.

    HHS-FDADue Jan 7, 2028$2,400,000